Evaluate Risks Before Prescribing a Flozin

November 2018

New safety concerns will raise questions about when to use an SGLT2 inhibitor (Invokana, etc) for type 2 diabetes.

Flozins are in the spotlight lately...since some may have cardiovascular and renal benefits.

But we know flozins have risks...yeast infections, UTIs, hypotension, acute kidney injury, rare ketoacidosis or fractures, etc.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote